bioAffinity Technologies (BIAF) Enterprise Value: 2022-2025
Historic Enterprise Value for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to -$4.9 million.
- bioAffinity Technologies' Enterprise Value fell 115.77% to -$4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.2 million, marking a year-over-year decrease of 129.11%. This contributed to the annual value of $13.1 million for FY2024, which is 17.26% up from last year.
- As of Q3 2025, bioAffinity Technologies' Enterprise Value stood at -$4.9 million, which was down 169.64% from $7.0 million recorded in Q2 2025.
- In the past 5 years, bioAffinity Technologies' Enterprise Value ranged from a high of $31.0 million in Q3 2024 and a low of -$4.9 million during Q3 2025.
- Moreover, its 3-year median value for Enterprise Value was $7.0 million (2023), whereas its average is $11.1 million.
- Per our database at Business Quant, bioAffinity Technologies' Enterprise Value spiked by 463.82% in 2023 and then plummeted by 115.77% in 2025.
- Quarterly analysis of 4 years shows bioAffinity Technologies' Enterprise Value stood at $2.0 million in 2022, then skyrocketed by 463.82% to $11.2 million in 2023, then climbed by 17.26% to $13.1 million in 2024, then plummeted by 115.77% to -$4.9 million in 2025.
- Its Enterprise Value stands at -$4.9 million for Q3 2025, versus $7.0 million for Q2 2025 and $4.3 million for Q1 2025.